YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Pfizer to produce COVID-19 drug at Kansas plant

Posted online

Pfizer Inc. entered a deal to produce Gilead Sciences Inc.’s remdesivir drug at a plant in McPherson, Kansas.

There's been a shortage of remdesivir after the Food and Drug Administration gave emergency authorization for its use as treatment for COVID-19 patients.

Financial terms of the multiyear deal were not disclosed.

Read more from the Kansas City Business Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Business Spotlight: Just the Type

After discovering a niche for vintage typewriters, Laura Prather quickly grew a home-based typewriter sale and service business.

Most Read
Update cookies preferences